CogState Ltd
ASX:CGS

Watchlist Manager
CogState Ltd Logo
CogState Ltd
ASX:CGS
Watchlist
Price: 1.06 AUD -2.75% Market Closed
Market Cap: 183.1m AUD
Have any thoughts about
CogState Ltd?
Write Note

CogState Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CogState Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
CogState Ltd
ASX:CGS
Capital Expenditures
-$1.9m
CAGR 3-Years
17%
CAGR 5-Years
5%
CAGR 10-Years
-10%
Mach7 Technologies Ltd
ASX:M7T
Capital Expenditures
AU$26.4k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
Capital Expenditures
-AU$3.5m
CAGR 3-Years
-54%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
Capital Expenditures
-AU$6.7m
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
-2%
Medibio Ltd
ASX:MEB
Capital Expenditures
-AU$2.3m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Capital Expenditures
-AU$1.8m
CAGR 3-Years
-67%
CAGR 5-Years
-78%
CAGR 10-Years
-21%
No Stocks Found

CogState Ltd
Glance View

Market Cap
181m AUD
Industry
Health Care

Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.

CGS Intrinsic Value
1.1 AUD
Undervaluation 4%
Intrinsic Value
Price

See Also

What is CogState Ltd's Capital Expenditures?
Capital Expenditures
-1.9m USD

Based on the financial report for Jun 30, 2024, CogState Ltd's Capital Expenditures amounts to -1.9m USD.

What is CogState Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-10%

Over the last year, the Capital Expenditures growth was 15%. The average annual Capital Expenditures growth rates for CogState Ltd have been 17% over the past three years , 5% over the past five years , and -10% over the past ten years .

Back to Top